Empfield James R.
- SEC CIK
- 0001665430
No open-market purchases or sales filed in the past year.
Current role at each company
- XENE Xenon Pharmaceuticals Inc.EVP, Drug Discoveryas of Mar 12, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Empfield James R. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 (view filing) | Aug 12 | 4 days | Empfield James R.EVP, Drug Discovery | SSale | −57.7K | $38.31 | −$2.21M | −85.2%10.0K after | 2 lots |
| Mar 8, 2022 (view filing) | Mar 4-7 | 4 days | Empfield James R.EVP, Drug Discovery | SSale | −51.2K | $30.63 | −$1.57M | −83.7%10.0K after | 3 lots |